Holen Sie sich die Stockscreener-App
0.5177
4.66%
-0.0253
Vorhandelsmarkt:
.53
0.0123
+2.38%
Schlusskurs vom Vortag:
$0.543
Offen:
$0.5473
24-Stunden-Volumen:
3.72M
Relative Volume:
0.18
Marktkapitalisierung:
$51.39M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-12.89M
KGV:
-0.2046
EPS:
-2.53
Netto-Cashflow:
$-11.95M
1W Leistung:
-14.05%
1M Leistung:
-29.20%
6M Leistung:
-20.10%
1J Leistung:
-61.65%
1-Tages-Spanne:
$0.5036
$0.552
1-Wochen-Bereich:
$0.486
$0.6149
52-Wochen-Spanne:
$0.1634
$2.3099
Plus Therapeutics Inc Stock (PSTV) Company Profile
Firmenname
Plus Therapeutics Inc
Sektor
Branche
Telefon
737.255.7194
Adresse
4200 MARATHON BLVD., AUSTIN, TX
Vergleichen Sie PSTV mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PSTV
Plus Therapeutics Inc
|
0.5177 | 53.90M | 0 | -12.89M | -11.95M | -2.53 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Plus Therapeutics Inc Stock (PSTV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-03 | Hochstufung | D. Boral Capital | Hold → Buy |
| 2025-03-17 | Eingeleitet | D. Boral Capital | Buy |
| 2021-01-25 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2020-10-16 | Eingeleitet | Maxim Group | Buy |
Plus Therapeutics Inc Aktie (PSTV) Neueste Nachrichten
What MACD signals say about Plus Therapeutics Inc.Earnings Risk Summary & Free High Return Stock Watch Alerts - newser.com
How Recent Developments Are Rewriting the Plus Therapeutics Investment Story - Yahoo Finance
Will Plus Therapeutics Inc. stock gain from strong economyDay Trade & Daily Profit Focused Screening - newser.com
How to use Fibonacci retracement on Plus Therapeutics Inc.Share Buyback & Daily Volume Surge Trade Alerts - newser.com
Why global investors buy Plus Therapeutics Inc. (XMP0) stockPortfolio Return Report & Fast Gain Stock Trading Tips - newser.com
Is Plus Therapeutics Inc. forming a reversal patternJuly 2025 Trends & Weekly Market Pulse Alerts - newser.com
How interest rate cuts could boost Plus Therapeutics Inc. stock2025 Price Momentum & Consistent Growth Stock Picks - newser.com
Is Plus Therapeutics Inc. forming a bottoming baseEarnings Recap Report & Advanced Swing Trade Entry Alerts - newser.com
Will Plus Therapeutics Inc. outperform the marketBreakout Watch & Verified Technical Trade Signals - newser.com
Plus Therapeutics stock price target lowered to $2 at H.C. Wainwright - Investing.com UK
Smart tools for monitoring Plus Therapeutics Inc.’s price action2025 AllTime Highs & Daily Volume Surge Trade Alerts - newser.com
Plus Therapeutics (PSTV) Analyst Rating Update: Price Target Low - GuruFocus
HC Wainwright & Co. Maintains Plus Therapeutics (PSTV) Buy Recommendation - Nasdaq
How dovish Fed policy supports Plus Therapeutics Inc. (XMP0) stock2025 Market Sentiment & Consistent Income Trade Ideas - newser.com
Order flow analysis tools used on Plus Therapeutics Inc.Insider Buying & Step-by-Step Swing Trade Plans - newser.com
Can Plus Therapeutics Inc. rally from current levelsJuly 2025 Levels & Daily Oversold Bounce Ideas - newser.com
Applying Wyckoff theory to Plus Therapeutics Inc. stock2025 Analyst Calls & Daily Technical Forecast Reports - newser.com
Will Plus Therapeutics Inc. benefit from macro trendsGlobal Markets & Expert Curated Trade Setup Alerts - newser.com
How Plus Therapeutics Inc. (XMP0) stock compares with tech leadersTrade Entry Report & Smart Money Movement Tracker - newser.com
What momentum shifts mean for Plus Therapeutics Inc.Market Sentiment Review & Fast Gain Stock Trading Tips - newser.com
Can a trend reversal in Plus Therapeutics Inc. lead to recoveryMarket Activity Recap & Accurate Intraday Trading Signals - newser.com
Candlestick signals on Plus Therapeutics Inc. stock todayQuarterly Risk Review & Safe Capital Growth Stock Tips - newser.com
Should you hold or exit Plus Therapeutics Inc. nowTrend Reversal & Daily Momentum Trading Reports - newser.com
Why Plus Therapeutics Inc. stock remains on watchlistsRisk Management & Daily Risk Controlled Trade Plans - newser.com
Applying Elliott Wave Theory to Plus Therapeutics Inc.Market Sentiment Review & Free Technical Pattern Based Buy Signals - newser.com
Is Plus Therapeutics Inc. stock positioned for long term growthMarket Risk Report & Real-Time Market Trend Scan - newser.com
Is Plus Therapeutics Inc. (XMP0) stock attractive for growth funds2025 Trading Recap & Free Daily Entry Point Trade Alerts - newser.com
Can Plus Therapeutics Inc. stock outperform in 2025 bull marketQuarterly Trade Summary & Weekly Consistent Profit Watchlists - newser.com
Plus Therapeutics, Inc. (NASDAQ:PSTV) Given Average Rating of "Buy" by Brokerages - MarketBeat
Is Plus Therapeutics Inc. stock positioned for digital transformation2025 Year in Review & Daily Momentum Trading Reports - newser.com
D. Boral Capital Reiterates Buy Rating for Plus Therapeutics (NASDAQ:PSTV) - MarketBeat
Is Plus Therapeutics Inc. stock dividend yield sustainableQuarterly Profit Report & Technical Entry and Exit Tips - newser.com
MSN Money - MSN
Plus Therapeutics’ ARISE Study: A New Hope for Fertility Treatment - MSN
Is Plus Therapeutics Inc. (XMP0) stock protected from inflationJuly 2025 Analyst Calls & Scalable Portfolio Growth Ideas - newser.com
Plus Therapeutics (NASDAQ:PSTV) Issues Earnings Results, Misses Expectations By $0.02 EPS - MarketBeat
PSTV: Analyst Maintains 'Buy' Rating and $5 Price Target Today | - GuruFocus
Plus Therapeutics Eyes Expansion Despite Wider Quarterly Loss - Finimize
D. Boral Capital Maintains Plus Therapeutics (PSTV) Buy Recommendation - Nasdaq
What MACD and RSI say about Plus Therapeutics Inc.Quarterly Portfolio Review & Low Volatility Stock Suggestions - newser.com
Finanzdaten der Plus Therapeutics Inc-Aktie (PSTV)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):